Editorial: Drug development of herbal medicines: Regulatory perspectives
Front Pharmacol
.
2022 Nov 10:13:989934.
doi: 10.3389/fphar.2022.989934.
eCollection 2022.
Authors
Anna Rita Bilia
1
,
Pulok Kumar Mukherjee
2
,
Adolfo Andrade-Cetto
3
,
Chandra Kant Katiyar
4
,
Sitesh C Bachar
5
,
Motlalepula Gilbert Matsabisa
6
,
Subhash C Mandal
7
Affiliations
1
Department of Chemistry "Ugo Schiff", University of Florence, Firenze, Italy.
2
Institute of Bio-Resources and Sustainable Development (IBSD), Imphal, India.
3
National Autonomous University of Mexico, México City, Mexico.
4
CEO Health Care (Technical), Emami Ltd., Kolkata, India.
5
Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
6
University of the Free State, Bloemfontein, South Africa.
7
Society for Ethnopharmacology India, Kolkata, India.
PMID:
36438850
PMCID:
PMC9686364
DOI:
10.3389/fphar.2022.989934
No abstract available
Keywords:
TCM; ayurveda; botanicals; herbal medicine; regulatory perspectives.
Publication types
Editorial